Soleno Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -494 | -490 | ||
EBITDA | -49,476 | -78,835 | -22,737 | -22,584 |
EBIT | -49,979 | -79,335 | -23,231 | -23,074 |
Net Income | -55,982 | -76,616 | -21,854 | -21,398 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -23,999 | -15,117 | -17,659 | -12,539 |
Cash | 87,928 | 48,413 | 57,024 | 42,847 |
Basic Shares | 43,924 | 41,879 | 38,631 | 36,208 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,958 | -2,210 | -2,207 | |
EBITDA | -37,030 | -21,857 | -28,703 | |
EBIT | -38,988 | -24,067 | -30,910 | |
Net Income | -175,850 | -38,988 | -20,319 | -29,561 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -69,314 | -24,940 | -20,794 | -27,792 |
Cash | 87,928 | 169,681 | 14,602 | 21,304 |
Basic Shares | 40,175 | 16,492 | 8,397 | 5,318 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$1.27 |
2024-09-30 | -$1.83 |
2024-06-30 | -$0.57 |
2024-03-31 | -$0.59 |
